147 related articles for article (PubMed ID: 12153007)
1. Myelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with 2-deoxycoformycin.
Todd SA; Morris TC; Alexander HD
Leuk Lymphoma; 2002 Jun; 43(6):1343-4. PubMed ID: 12153007
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature.
Hassan R; Gupta M; Kern W; Ozer H
Leuk Lymphoma; 2004 Oct; 45(10):2149-52. PubMed ID: 15370263
[TBL] [Abstract][Full Text] [Related]
3. Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature.
Al-Fiar F; Meharchand J; Curtis J; Lipton JH
Leuk Res; 1999 Aug; 23(8):719-21. PubMed ID: 10456669
[TBL] [Abstract][Full Text] [Related]
4. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin.
Ng JP; Nolan B; Chan-Lam D; Coup AJ; McKenna D
Hematology; 2002 Aug; 7(4):259-62. PubMed ID: 14972788
[TBL] [Abstract][Full Text] [Related]
6. Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia.
Psiachou-Leonard E; Bain BJ
Clin Lab Haematol; 1998 Jun; 20(3):195-7. PubMed ID: 9681239
[TBL] [Abstract][Full Text] [Related]
7. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
8. Second malignancies in patients with hairy cell leukemia in british columbia: a 20-year experience.
Au WY; Klasa RJ; Gallagher R; Le N; Gascoyne RD; Connors JM
Blood; 1998 Aug; 92(4):1160-4. PubMed ID: 9694703
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin].
Nagai T; Izumi T; Noborio K; Takatoku M; Ohtsuki T; Machii T; Komatsu N; Ozawa K
Rinsho Ketsueki; 2002 Jul; 43(7):583-5. PubMed ID: 12229130
[TBL] [Abstract][Full Text] [Related]
11. Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy.
Gillis S; Amir G; Bennett M; Polliack A
Eur J Haematol; 2001 Jan; 66(1):7-10. PubMed ID: 11168501
[TBL] [Abstract][Full Text] [Related]
12. Long term outcome of patients with hairy cell leukemia treated with pentostatin.
Ribeiro P; Bouaffia F; Peaud PY; Blanc M; Salles B; Salles G; Coiffier B
Cancer; 1999 Jan; 85(1):65-71. PubMed ID: 9921975
[TBL] [Abstract][Full Text] [Related]
13. Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine.
Seshadri P
Leuk Res; 2000 Jul; 24(7):637. PubMed ID: 10979762
[No Abstract] [Full Text] [Related]
14. Synchronous gastric and ampullary adenocarcinomas in a hairy cell leukemia patient treated with pentostatin eight years prior.
Senatore FJ; Dasanu CA
J Oncol Pharm Pract; 2016 Jun; 22(3):543-7. PubMed ID: 25712625
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hairy-cell leukemia: current views.
Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.
Shimoyama M; Tobinai K; Yamaguchi K; Hirashima K; Itoh S; Konishi H; Mikuni C; Togawa A; Hotta T; Toyoda N
Jpn J Clin Oncol; 1992 Dec; 22(6):406-10. PubMed ID: 1291757
[TBL] [Abstract][Full Text] [Related]
17. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
19. CD56-Positive Acute Myeloid Leukemia Following Treatment of Hairy Cell Leukemia with Cladribine - Report of 2 Cases and Review of the Literature.
Colovic N; Marisavljevic D; Kraguljac-Kurtovic N; Bogdanovic A; Gotic M
Arch Iran Med; 2019 May; 22(5):269-271. PubMed ID: 31256601
[TBL] [Abstract][Full Text] [Related]
20. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Spiers AS
Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
